218 related articles for article (PubMed ID: 25606368)
1. A comparison of psychiatric diagnoses among HIV-infected prisoners receiving combination antiretroviral therapy and transitioning to the community.
Di Paola A; Altice FL; Powell ML; Trestman RL; Springer SA
Health Justice; 2014 Oct; 2(11):. PubMed ID: 25606368
[TBL] [Abstract][Full Text] [Related]
2. Substance abuse and personality disorder comorbidity in adolescent outpatients: are girls more severely ill than boys?
Korsgaard HO; Torgersen S; Wentzel-Larsen T; Ulberg R
Child Adolesc Psychiatry Ment Health; 2016; 10():8. PubMed ID: 27069507
[TBL] [Abstract][Full Text] [Related]
3. The UNCOPE: An effective brief screen for DSM-5 substance use disorders in correctional settings.
Proctor SL; Hoffmann NG
Psychol Addict Behav; 2016 Aug; 30(5):613-618. PubMed ID: 27136373
[TBL] [Abstract][Full Text] [Related]
4. A Review of Opportunities to Improve the Health of People Involved in the Criminal Justice System in the United States.
Freudenberg N; Heller D
Annu Rev Public Health; 2016; 37():313-33. PubMed ID: 26789388
[TBL] [Abstract][Full Text] [Related]
5. Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS.
Polonsky M; Azbel L; Wickersham JA; Taxman FS; Grishaev E; Dvoryak S; Altice FL
Drug Alcohol Depend; 2015 Mar; 148():47-55. PubMed ID: 25620732
[TBL] [Abstract][Full Text] [Related]
6. Managing HIV/AIDS in correctional settings.
Springer SA; Altice FL
Curr HIV/AIDS Rep; 2005 Nov; 2(4):165-70. PubMed ID: 16343373
[TBL] [Abstract][Full Text] [Related]
7. HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners.
Springer SA; Azar MM; Altice FL
Am J Drug Alcohol Abuse; 2011 Jan; 37(1):12-21. PubMed ID: 21171933
[TBL] [Abstract][Full Text] [Related]
8. Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment.
Gordon MS; Vocci FJ; Fitzgerald TT; O'Grady KE; O'Brien CP
Contemp Clin Trials; 2017 Feb; 53():130-136. PubMed ID: 28011389
[TBL] [Abstract][Full Text] [Related]
9. A cluster randomised controlled trial protocol of an adapted intervention for alcohol use disorders in people living with HIV and AIDS: impact on alcohol use, general functional ability, quality of life and adherence to HAART.
Madhombiro M; Dube-Marimbe B; Dube M; Chibanda D; Zunza M; Rusakaniko S; Stewart D; Seedat S
BMC Psychiatry; 2017 Jan; 17(1):44. PubMed ID: 28129756
[TBL] [Abstract][Full Text] [Related]
10. Self-reported psychotic disorders among Individuals with substance use disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
Lev-Ran S; Imtiaz S; Le Foll B
Am J Addict; 2012; 21(6):531-5. PubMed ID: 23082831
[TBL] [Abstract][Full Text] [Related]
11. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
12. HIV risk reduction and service delivery strategies in criminal justice settings.
Inciardi JA
J Subst Abuse Treat; 1996; 13(5):421-8; discussion 439. PubMed ID: 9142672
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled study of intervention to improve continuity care engagement among HIV-infected persons after release from jails.
Khawcharoenporn T; Cole J; Claus J; Bell T; Lewis A; Zawitz C; Kessler H
AIDS Care; 2019 Jul; 31(7):777-784. PubMed ID: 30304936
[TBL] [Abstract][Full Text] [Related]
14. Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community.
Springer SA; Di Paola A; Azar MM; Barbour R; Krishnan A; Altice FL
Drug Alcohol Depend; 2017 May; 174():158-170. PubMed ID: 28334661
[TBL] [Abstract][Full Text] [Related]
15. Burden of substance use disorders, mental illness, and correlates of infectious diseases among soon-to-be released prisoners in Azerbaijan.
Azbel L; Wickersham JA; Wegman MP; Polonsky M; Suleymanov M; Ismayilov R; Dvoryak S; Rotberga S; Altice FL
Drug Alcohol Depend; 2015 Jun; 151():68-75. PubMed ID: 25861943
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey.
Wali A; Khan D; Safdar N; Shawani Z; Fatima R; Yaqoob A; Qadir A; Ahmed S; Rashid H; Ahmed B; Khan S
BMC Public Health; 2019 Dec; 19(1):1631. PubMed ID: 31801496
[TBL] [Abstract][Full Text] [Related]
17. Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?
Lucas GM; Flexner CW; Moore RD
AIDS Patient Care STDS; 2002 Nov; 16(11):527-35. PubMed ID: 12513901
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and predictors of no lifetime utilization of mental health treatment among people with mental disorders in France: findings from the 'Mental Health in General Population' (MHGP) survey.
Font H; Roelandt JL; Behal H; Geoffroy PA; Pignon B; Amad A; Simioni N; Vaiva G; Thomas P; Duhamel A; Benradia I; Rolland B
Soc Psychiatry Psychiatr Epidemiol; 2018 Jun; 53(6):567-576. PubMed ID: 29619580
[TBL] [Abstract][Full Text] [Related]
19. The association between combination antiretroviral adherence and AIDS-defining conditions at HIV diagnosis.
Abara WE; Xu J; Adekeye OA; Rust G
AIDS Care; 2016 Aug; 28(8):1013-7. PubMed ID: 26886075
[TBL] [Abstract][Full Text] [Related]
20. The validity of the Substance Abuse and Mental Illness Symptom Screener (SAMISS) in people living with HIV/AIDS in primary HIV care in Cape Town, South Africa.
Breuer E; Stoloff K; Myer L; Seedat S; Stein DJ; Joska JA
AIDS Behav; 2014 Jun; 18(6):1133-41. PubMed ID: 24452497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
